148 related articles for article (PubMed ID: 24571444)
41. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder.
Veenstra-VanderWeele J; Kim SJ; Gonen D; Hanna GL; Leventhal BL; Cook EH
Mol Psychiatry; 2001 Mar; 6(2):160-7. PubMed ID: 11317217
[TBL] [Abstract][Full Text] [Related]
42. Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1.
Stewart SE; Mayerfeld C; Arnold PD; Crane JR; O'Dushlaine C; Fagerness JA; Yu D; Scharf JM; Chan E; Kassam F; Moya PR; Wendland JR; Delorme R; Richter MA; Kennedy JL; Veenstra-VanderWeele J; Samuels J; Greenberg BD; McCracken JT; Knowles JA; Fyer AJ; Rauch SL; Riddle MA; Grados MA; Bienvenu OJ; Cullen B; Wang Y; Shugart YY; Piacentini J; Rasmussen S; Nestadt G; Murphy DL; Jenike MA; Cook EH; Pauls DL; Hanna GL; Mathews CA
Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):367-79. PubMed ID: 23606572
[TBL] [Abstract][Full Text] [Related]
43. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study.
Voyiaziakis E; Evgrafov O; Li D; Yoon HJ; Tabares P; Samuels J; Wang Y; Riddle MA; Grados MA; Bienvenu OJ; Shugart YY; Liang KY; Greenberg BD; Rasmussen SA; Murphy DL; Wendland JR; McCracken JT; Piacentini J; Rauch SL; Pauls DL; Nestadt G; Fyer AJ; Knowles JA
Mol Psychiatry; 2011 Jan; 16(1):108-20. PubMed ID: 19806148
[TBL] [Abstract][Full Text] [Related]
44. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder.
Zai G; Arnold P; Burroughs E; Barr CL; Richter MA; Kennedy JL
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):25-9. PubMed ID: 15685626
[TBL] [Abstract][Full Text] [Related]
45. ASSOCIATION STUDY BETWEEN OLIGODENDROCYTE TRANSCRIPTION FACTOR 2 GENE AND OBSESSIVE-COMPULSIVE DISORDER IN A CHINESE HAN POPULATION.
Zhang X; Liu J; Guo Y; Jiang W; Yu J
Depress Anxiety; 2015 Oct; 32(10):720-7. PubMed ID: 26271930
[TBL] [Abstract][Full Text] [Related]
46. Association between glutamate transporter gene polymorphisms and obsessive-compulsive disorder/trait empathy in a Korean population.
Kim HW; Kang JI; Hwang EH; Kim SJ
PLoS One; 2018; 13(1):e0190593. PubMed ID: 29304071
[TBL] [Abstract][Full Text] [Related]
47. Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia.
Arai S; Shibata H; Sakai M; Ninomiya H; Iwata N; Ozaki N; Fukumaki Y
Psychiatr Genet; 2009 Feb; 19(1):6-13. PubMed ID: 19125103
[TBL] [Abstract][Full Text] [Related]
48. TNF-alpha polymorphisms are associated with obsessive-compulsive disorder.
Hounie AG; Cappi C; Cordeiro Q; Sampaio AS; Moraes I; Rosário MC; Palácios SA; Goldberg AC; Vallada HP; Machado-Lima A; Nakano E; Kalil J; Pauls D; Pereira CA; Guilherme L; Miguel EC
Neurosci Lett; 2008 Sep; 442(2):86-90. PubMed ID: 18639610
[TBL] [Abstract][Full Text] [Related]
49. Association study between obsessive-compulsive disorder and serotonergic candidate genes.
Saiz PA; Garcia-Portilla MP; Arango C; Morales B; Bascaran MT; Martinez-Barrondo S; Florez G; Sotomayor E; Paredes B; Alvarez C; San Narciso G; Carreño E; Bombin I; Alvarez V; Coto E; Fernandez JM; Bousoño M; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):765-70. PubMed ID: 18191318
[TBL] [Abstract][Full Text] [Related]
50. Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis.
Geller D; Petty C; Vivas F; Johnson J; Pauls D; Biederman J
Biol Psychiatry; 2007 Jun; 61(12):1388-94. PubMed ID: 17241617
[TBL] [Abstract][Full Text] [Related]
51. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder.
Camarena B; Rinetti G; Cruz C; Gómez A; de La Fuente JR; Nicolini H
Am J Med Genet; 2001 Apr; 105(3):279-82. PubMed ID: 11353450
[TBL] [Abstract][Full Text] [Related]
52. Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder.
Alonso P; Gratacòs M; Segalàs C; Escaramís G; Real E; Bayés M; Labad J; Pertusa A; Vallejo J; Estivill X; Menchón JM
Psychoneuroendocrinology; 2011 May; 36(4):473-83. PubMed ID: 20850223
[TBL] [Abstract][Full Text] [Related]
53. Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder.
Real E; Gratacòs M; Labad J; Alonso P; Escaramís G; Segalàs C; Subirà M; López-Solà C; Estivill X; Menchón JM
Pharmacogenomics J; 2013 Oct; 13(5):470-5. PubMed ID: 22776887
[TBL] [Abstract][Full Text] [Related]
54. Association analysis of serotonin and catecholamine system candidate genes in obsessive-compulsive disorder in the Chinese population.
Liu W; Zhao N; Xiong J; Shi M; Hu J
Psychiatry Res; 2011 Jun; 188(1):170-2. PubMed ID: 20937529
[TBL] [Abstract][Full Text] [Related]
55. Population-based, multigenerational family clustering study of obsessive-compulsive disorder.
Mataix-Cols D; Boman M; Monzani B; Rück C; Serlachius E; Långström N; Lichtenstein P
JAMA Psychiatry; 2013 Jul; 70(7):709-17. PubMed ID: 23699935
[TBL] [Abstract][Full Text] [Related]
56. Serotonin system gene variants and regional brain volume differences in pediatric OCD.
Sinopoli VM; Erdman L; Burton CL; Easter P; Rajendram R; Baldwin G; Peterman K; Coste J; Shaheen SM; Hanna GL; Rosenberg DR; Arnold PD
Brain Imaging Behav; 2020 Oct; 14(5):1612-1625. PubMed ID: 31187473
[TBL] [Abstract][Full Text] [Related]
57. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder.
Carter AS; Pollock RA; Suvak MK; Pauls DL
Depress Anxiety; 2004; 20(4):165-74. PubMed ID: 15643633
[TBL] [Abstract][Full Text] [Related]
58. Early onset of obsessive-compulsive disorder and associated comorbidity.
Janowitz D; Grabe HJ; Ruhrmann S; Ettelt S; Buhtz F; Hochrein A; Schulze-Rauschenbach S; Meyer K; Kraft S; Ferber C; Pukrop R; Freyberger HJ; Klosterkötter J; Falkai P; John U; Maier W; Wagner M
Depress Anxiety; 2009; 26(11):1012-7. PubMed ID: 19691024
[TBL] [Abstract][Full Text] [Related]
59. A review of the role of serotonin system genes in obsessive-compulsive disorder.
Sinopoli VM; Burton CL; Kronenberg S; Arnold PD
Neurosci Biobehav Rev; 2017 Sep; 80():372-381. PubMed ID: 28576508
[TBL] [Abstract][Full Text] [Related]
60. Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes.
Lochner C; Hemmings SM; Kinnear CJ; Nel D; Hemmings SM; Seedat S; Moolman-Smook JC; Stein DJ
Isr J Psychiatry Relat Sci; 2008; 45(3):164-76. PubMed ID: 19398820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
